A deeper understanding of the bacterial pathways influencing drug efficacy can lead to better tuberculosis drug development and treatment. One such study has been conducted by Rockefeller University, USA, and published in the journal Nature Microbiology.

##Reference## Shuqi Li et al, CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis, Nature Microbiology (2022) ##